Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 23:14:1099541.
doi: 10.3389/fgene.2023.1099541. eCollection 2023.

Pharmacogenomics and health disparities, are we helping?

Sherin Shaaban  1   2 , Yuan Ji  1   2
Affiliations
Review

Pharmacogenomics and health disparities, are we helping?

Sherin Shaaban et al. Front Genet. .

Abstract

Pharmacogenomics has been at the forefront of precision medicine during the last few decades. Precision medicine carries the potential of improving health outcomes at both the individual as well as population levels. To harness the benefits of its initiatives, careful dissection of existing health disparities as they relate to precision medicine is of paramount importance. Attempting to address the existing disparities at the early stages of design and implementation of these efforts is the only guarantee of a successful just outcome. In this review, we glance at a few determinants of existing health disparities as they intersect with pharmacogenomics research and implementation. In our opinion, highlighting these disparities is imperative for the purpose of researching meaningful solutions. Failing to identify, and hence address, these disparities in the context of the current and future precision medicine initiatives would leave an already strained health system, even more inundated with inequality.

Keywords: disparities; equity; genetics; pharmacogenomics (PGx); precision medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abou-Ismail M. Y., Citla Sridhar D., Nayak L. (2020). Estrogen and thrombosis: A bench to bedside review. Thromb. Res. 192, 40–51. 10.1016/j.thromres.2020.05.008 - DOI - PMC - PubMed
    1. Adusumilli P., Konatam M. L., Gundeti S., Bala S., Maddali L. S. (2017). Treatment challenges and survival analysis of human epidermal growth factor receptor 2-positive breast cancer in real world. Indian J. Med. Paediatr. Oncol. 38 (1), 22–27. 10.4103/0971-5851.203511 - DOI - PMC - PubMed
    1. Ahsan T., Urmi N. J., Sajib A. A. (2020). Heterogeneity in the distribution of 159 drug-response related SNPs in world populations and their genetic relatedness. PLoS One 15, e0228000. 10.1371/journal.pone.0228000 - DOI - PMC - PubMed
    1. Al-Sadawi M., Hussain Y., Copeland-Halperin R. S., Tobin J. N., Moskowitz C. S., Dang C. T., et al. (2021). Racial and socioeconomic disparities in cardiotoxicity among women with HER2-positive breast cancer. Am. J. Cardiol. 147, 116–121. 10.1016/j.amjcard.2021.02.013 - DOI - PMC - PubMed
    1. Alzubiedi S., Saleh M. I. (2016). Pharmacogenetic-guided warfarin dosing algorithm in african-Americans. J. Cardiovasc Pharmacol. 67, 86–92. 10.1097/FJC.0000000000000317 - DOI - PubMed

LinkOut - more resources